Pretherapeutic 124I dosimetry reliably predicts intratherapeutic blood kinetics of 131I in patients with differentiated thyroid carcinoma receiving high therapeutic activities

Conclusion The pretherapeutic blood kinetics derived from diagnostic 124I activities provides a reliable estimation of the intratherapeutic 131I blood kinetics in patients receiving largely high therapy activities, showing its potential for radioiodine treatment planning.
Source: Nuclear Medicine Communications - Category: Nuclear Medicine Tags: Original Articles Source Type: research